M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Zoraida Soriano, Joel D Pardee

Abstract

At present, there is no available molecular marker that reliably detects the earliest stages of epithelial transformation in the majority of patients affected with incipient breast carcinoma. Here we introduce M34 protein, a mammalian actin filament regulatory protein, as a highly sensitive and easily detected positive cellular marker for both early and late stages of breast carcinoma. In this study, 24 human lactation duct neoplasms from postmenopausal women, including fibroadenoma, ductal carcinoma in situ, intraductal lobular papilloma, and metastatic adenocarcinoma, were analyzed for the presence of M34 protein by histochemical staining of paraffin and fresh-frozen sections. All 24 neoplasias tested positive for M34, whereas none of the 4 normal breast tissues stained for the protein. M34 identification was strongly positive for transformed epithelium in all tumor types tested. Twelve precancerous lesions of fibroadenoma (n = 4), intraductal papilloma (n = 4), and incipient ductal carcinoma in situ (n = 4) all showed high levels of M34 staining, suggesting that precancerous tumors, as well as the earliest stages of mammary carcinoma, can be sensitively detected. Furthermore, anti-M34 antibody selectively stained all 12 adva...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Mar 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P R RosenS Hellman
Nov 15, 1973·Journal of Molecular Biology·U K Laemmli, M Favre
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·U GlückA Ben-Ze'ev
Jun 1, 1997·Current Opinion in Genetics & Development·C J Rawlings, D B Searls
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S L JonesE J Brown
May 23, 2001·Breast Cancer Research and Treatment·A L SilvaJ L Passos-Coelho
Sep 13, 2001·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·F CañizaresP Martínez
Oct 30, 2001·Scandinavian Journal of Clinical and Laboratory Investigation·J SjöströmC Blomqvist
Dec 18, 2001·The Journal of Pathology·R A Walker
Jan 30, 2002·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael Thun
May 7, 2002·Nature Reviews. Cancer·David Sidransky

❮ Previous
Next ❯

Citations

Nov 6, 2007·Acta Neuropathologica·Richard C DavisMarcus Fechheimer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.